Navigation Links
Facet Life Sciences Appoints Tobias Massa, PhD to Board of Directors
Date:9/12/2017

Facet Life Sciences, a leading provider of development solutions (software and services) for small and growing life sciences teams, today announced that Tobias Massa, PhD has joined the company’s Board of Directors.

Dr. Massa brings 38 years of success in pharmaceuticals, biotech, life sciences, and technology to his Board position. Most recently he served as VP and Head of Global Regulatory Operations at Sanofi. During his tenure, he spearheaded multiple organizational change projects including the creation of an outsourcing program for non-strategic regulatory activity; strategic planning for the establishment of a regulatory outsourcing center; the consolidation of regulatory processes and tools; and the development of a foundation for the transition of traditional services to a multi-tenant cloud-based SaaS system. Prior to Sanofi, Dr. Massa spent ten years at Bristol-Myers Squibb where he led Global Regulatory CMC/Operations/ Mature Product Strategy.

Ken VanLuvanee, President and CEO, Facet Life Sciences, commented, “Toby has an incredible career-spanning track record of innovation. He understands life sciences R&D but more importantly, he has practical, experience-based insight into how we can improve it. His pioneering attitude aligns well with our innovative technology and service strategy designed for small teams. We look forward to his contributions as a member of the Facet Board of Directors.”

Dr. Massa added, “In the life sciences industry, so many novel products are being produced by very small development teams. This is the segment of the market where science and innovation are flourishing. I am excited to work with the Facet Life Sciences team because they are so dedicated to this under-served group.”

The Facet Life Sciences Board of Directors also includes Ken VanLuvanee, President and CEO and Lisa Jenkins VanLuvanee, Vice President, Research and Development.

About Facet Life Sciences
Facet Life Sciences is the leading provider of innovative development solutions (software and services) designed to help small teams get their INDs to and through the FDA. Our research and development specialists deliver expert services and cutting-edge technologies that speed product R&D efforts. Facet teams create and manage critical development documentation for some of the industry’s fastest growing life sciences companies.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14676958.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease
2. Elseviers Geofacets Adds More Than 80,000 Maps in Collaboration with The Geological Society of America
3. CNA Finance Initiates Research Coverage On NuLife Sciences
4. Beckman Coulter Life Sciences to Discuss Particles and Composition of Tuberculosis Vaccine
5. Akadeum Life Sciences, Inc. Recognized for Best New Technology at CYTO Innovation
6. Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections
7. Panitch Schwarze Life Sciences Practice Leader Speaks at Biotechnology Conference in Shanghai
8. OHAUS Introduces New Line of Laboratory Equipment for the Life Sciences
9. ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug
10. Life Sciences Expert Navitas augments End-to-end Capabilities
11. Beckman Coulter Life Sciences to Showcase Analytical Methods to Measure Empty and Full AAV Particles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2017)... Diego, CA (PRWEB) , ... September 15, 2017 ... ... Grolltex, has recently closed what it calls an ‘Internal Seed B’ round of ... the company’s stock and was completed using a ‘SAFE’ documentation structure at a ...
(Date:9/14/2017)... ... September 14, 2017 , ... DrugDev ... biotech at the third annual DrugDev Summit, November 7-8, 2017 in Philadelphia, PA. ... most progressive clinical research leaders for best practice case studies, keynote presentations, lively ...
(Date:9/14/2017)... ... September 14, 2017 , ... Boston Strategic ... experience with Health Economics and Outcomes Research (HEOR) and ‘big data’ to provide ... 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. ...
(Date:9/14/2017)... ... 2017 , ... One of the world’s largest World Marrow Donor Day events ... that day, the GenCure Marrow Donor Program will be signing up potential donors for ... San Antonio. , The registration tables will be staffed by employees from all the ...
Breaking Biology Technology:
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):